The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Tevimbra (tislelizumab)
Australian Public Assessment Report
Device/Product Name
Tevimbra
Active ingredients
Tislelizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-02507-1-4
Submission Type
New chemical entity
Decision
Approved